Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

2.56
-0.0700-2.66%
Post-market: 2.580.0200+0.78%19:30 EDT
Volume:3.37M
Turnover:8.75M
Market Cap:281.02M
PE:-15.06
High:2.69
Open:2.59
Low:2.54
Close:2.63
52wk High:5.45
52wk Low:2.42
Shares:109.77M
Float Shares:85.39M
Volume Ratio:1.46
T/O Rate:3.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:0.76
PE(LYR):-1.27

Loading ...

Rocket Pharmaceuticals, - FDA Confirms Pivotal Efficacy Population of 12 Patients for Rp-A501 Trial

THOMSON REUTERS
·
Sep 15

Q32 Bio Names José Trevejo Chief Medical Officer

Reuters
·
Sep 14

Rocket Pharma to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 03

Rocket Pharmaceuticals Price Target Maintained with a $11.00/Share by Chardan Capital

Dow Jones
·
Sep 01

Rocket Adopts Severance, Change-in-Control Program for US Employees, Executives

Reuters
·
Aug 28

Don't Ignore The Insider Selling In Rocket Pharmaceuticals

Simply Wall St.
·
Aug 15

MacroGenics Q2 Revenue Misses Estimates, Posts Profit on Asset Sale

Reuters
·
Aug 14

MeiraGTx Q2 Revenue Jumps on Reogen License Revenue

Reuters
·
Aug 13

Rocket Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Abeona Therapeutics Q2 Net Loss Widens, Misses Analyst Expectations

Reuters
·
Aug 13

Rocket Pharmaceuticals' Danon, PKP2-ACM Updates Seen as Key H2 Catalysts, Wedbush Says

MT Newswires Live
·
Aug 12

Rocket Pharmaceuticals Price Target Cut to $15.00/Share from $16.00 by Wedbush

Dow Jones
·
Aug 11

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)

TIPRANKS
·
Aug 11

Wedbush Adjusts PT on Rocket Pharmaceuticals to $15 From $16, Keeps Outperform Rating

MT Newswires Live
·
Aug 11

Cantor Fitzgerald Keeps Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 11

Rocket Pharmaceuticals, Inc. Expected to Post a Loss of 42 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 11

Rocket Pharmaceuticals, Inc. : Leerink Partners Cuts Target Price to $7 from $12

THOMSON REUTERS
·
Aug 11

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 11

Rocket Pharmaceuticals Q2 Adj. EPS $(0.37) Misses $0.24 Estimate

Benzinga Earnings
·
Aug 11